Hamed Tewfik practices Radiation Oncology. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Hamed Tewfik has written publications. He has 43 publications published with PubMed. The lastest paper is: 'Olsalazine is contraindicated during pelvic radiation therapy: results of a double-blind, randomized clinical trial.' Hamed Tewfik accepts all Medicare patients.
| NPI NUMBER | 1437144144 | |
| NPPES Provider LastName | TEWFIK | |
| NPPES Provider FirstName | HAMED | |
| NPPES Provider ZIPCode | 522459572 | |
| NPPES Provider State | IA | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 77.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
| National Provider Identifier [NPI] | 1437144144 |
| Last Name Of The Provider | TEWFIK |
| First Name Of The Provider | HAMED |
| View All |
|
Dr. Casey E. Duncan, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. William L. McGinnis, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Hani M. Al-Ali, MD |
|
Dr. Andrew C. Hoover, MD |
|
Dr. Daniel J. Ferraro, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Darrion L. Mitchell, MD |
|
Dr. Edwin J. VanBeek Jr., MD |
|
Wenqing Sun, MB
This Doctor is OpenDoctor Recommended.
|